LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $9 million in its third quarter.

On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 16 cents.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.

The gene therapy company posted revenue of $24.6 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $12.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR